Key result
Haemodialysis patients had significantly greater carotid intima-media thickness compared to controls (p<0.001) and predialysis patients (p<0.001).
Why the study?
The study aimed to assess the morphological characteristics of carotid blood vessels in uremic patients prior to dialysis initiation and correlate findings across various dialysis therapy modalities.
Does the type of dialysis treatment affect carotid intima-media thickness and lipid status in patients with end-stage renal disease?
Cross-Sectional (n=105)
Does the type of dialysis treatment affect carotid intima-media thickness and lipid status in patients with end-stage renal disease?
p-value: p=<0.001
Patients on haemodialysis have significantly greater carotid intima-media thickness compared to predialysis patients and healthy controls, suggesting an association with higher cardiovascular risk.
Thicker CIMT in haemodialysis patients signals higher CV risk; leaves open whether dialysis stage drives atherosclerosis progression.
Aim To assess morphological characteristics of carotid blood vessels in uremic patients before to the initiation of the dialysis treatment, and corelate data with various dialysis therapy modules. Methods The study included 30 patients with end-stage renal disease (ERDS) prior to commencing dialysis, 30 patients treated with haemodialysis and 30 patients treated with continuous ambulatory peritoneal dialysis. The control group consisted of 15 subjects with normal kidney function (eGFR>60ml/min). Carotid intima-media thickness (CIMT), as well as lipid status values (cholesterol, triglycerides, low-density lipoprotein (LDL), high-density lipoprotein (HDL), apolipoprotein A, apolipoprotein B) were evaluated. Results The significant difference in CIMT was detected between the control and haemodialysis groups (p<0.001), and between the control and the peritoneal dialysis group (p=0.004). In patients in the predialysis group, CIMT was influenced by cholesterol (p=0.013), HDL (p=0.044), LDL (p=0.001) and ApoB (p=0.042) values. A significant difference in CIMT was proved between the haemodialysis and predialysis group of patients (p<0.001). The only variable from the patient's lipometabolic profile significantly associated with the change in IMT in uremic patients was HDL. A significant difference was found in the average value for systolic blood pressure (p<0.001) and diastolic blood pressure (p=0.018) in patients before starting the dialysis treatment compared to patients treated with other dialysis methods. Conclusion Patients on haemodialysis treatment had a significantly greater CIMT, which is in relation with a higher cardiovascular risk.
No takes yet. Share an insight, caveat, or question.
Rebić et al. (2022) conducted a cross-sectional in End-stage renal disease (n=105). Haemodialysis vs. Normal kidney function (control) and predialysis was evaluated on Carotid intima-media thickness (CIMT) (p=<0.001). Haemodialysis patients had significantly greater carotid intima-media thickness compared to controls (p<0.001) and predialysis patients (p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: